
AI
Isomorphic Labs raises $5 billion to put AI-designed drugs into trials
Demis Hassabis's AI drug company closed a $5 billion Series C, six months after a $2.1 billion round, and says it is heading toward its first clinical trials.
Tag
1 stories

Demis Hassabis's AI drug company closed a $5 billion Series C, six months after a $2.1 billion round, and says it is heading toward its first clinical trials.